Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of the 28-Day Oral Contraceptive DR-1021

NCT00362479 is registered in ClinicalTrials.gov with Duramed Research as lead sponsor.

NCT NCT00362479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00362479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of the 28-Day Oral Contraceptive DR-1021
Lead sponsor
Duramed Research
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2006
Completion date
July 31, 2007
Enrollment
1,347 (actual)
Sites
85

Conditions

As the registry lists them; a condition with its own page is linked.

contraception